Softmax Co., Ltd

3671.T
Health Information Services
2026/08/12 Updated
Market Cap: $47.1M (¥7.5B)
Stock Price: $1.96 (¥312)
Exchange Rate: 1 USD = ¥159.24

Softmax Corporation 2026 Fiscal Year December Period Q2 Interim Financial Summary

The results for the 2nd quarter of the 2026 fiscal year ( Interim period ) show trends in revenue and various profit metrics year-on-year, with notes related to segment disclosure materials. The current narrative focuses on financial condition, performance, and outlook.

Importance:
Page Updated: August 12, 2026
IR Disclosure Date: August 12, 2026

Key Figures

  • Revenue: Unknown
  • Operating income: Unknown
  • Net income: Unknown

AI要約

Overview of Performance

The text is the Financial Summary for the second quarter of the 2026 fiscal year and includes explanations of management performance and financial position. It notes the breakdown of revenue and profit by segment, asset and liability positions, cash flows, and assumptions for earnings guidance. At this time, specific values for key indicators are not disclosed, but trends in revenue and profit items, underlying assumptions, and asset composition are indicated.

Impact on Shareholders / Outlook

Notes discuss movements in accounts receivable, notes and jubilees, inventories, and fixed assets, changes in capital structure, and cash flow indicators affecting financial soundness. Going forward, while numbers are not yet disclosed, there may be updates or revisions to earnings assumptions and possible use of funds for investment activities that readers should watch for.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Softmax Corporation

Company overview · Stock price · Financial data · All IR

View company page →